BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38125198)

  • 1. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9783040. PubMed ID: 37502536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Multiomics Immune-Related lncRNA Analysis of Oral Squamous Cell Carcinoma and Its Correlation with Prognosis.
    Markers D
    Dis Markers; 2023; 2023():9861260. PubMed ID: 37387768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
    International BR
    Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
    International BR
    Biomed Res Int; 2022; 2022():9829634. PubMed ID: 36605105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9898076. PubMed ID: 37860331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: Implications of Human Antimicrobial Peptide Defensin Beta-1 in Clinical Oral Squamous Cell Carcinoma Patients via an Integrated Bioinformatics Approach.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9820871. PubMed ID: 38094444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retracted: Biogenic Analysis of the Effect of TERC on Cell Proliferation and Migration of Oral Squamous Cell Carcinoma under Digital Minimally Invasive Treatment.
    International BR
    Biomed Res Int; 2023; 2023():9798465. PubMed ID: 37388366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: MCU That Is Transcriptionally Regulated by Nrf2 Augments Malignant Biological Behaviors in Oral Squamous Cell Carcinoma Cells.
    International BR
    Biomed Res Int; 2024; 2024():9840106. PubMed ID: 38230029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9847941. PubMed ID: 37811260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9858395. PubMed ID: 38550122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retracted] Effect of microRNA-27b on cisplatin chemotherapy sensitivity of oral squamous cell carcinoma via FZD7 signaling pathway.
    Liu B; Cao G; Dong Z; Guo T
    Oncol Lett; 2024 Jun; 27(6):275. PubMed ID: 38690102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retracted: Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9820845. PubMed ID: 37565232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9893453. PubMed ID: 37387739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.